NCT00326898-D2
Dataset Information
Dataset ID: NCT00326898-D2
PubMed ID (PMID):
Publication Title:
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Description of Dataset:
As of November 6, 2017, there are four different datasets available for NCT00326898. This is NCT00326898-D2. NCT00326898-D1 and NCT00326898-D3 each contain the same clinical data. NCT00326898-D2 and NCT00326898-D4 each contain the same toxicity data. NCT00326898-D1 and NCT00326898-D2 were the original two submissions. NCT00326898-D3 and NCT00326898-D4 updated the original data submissions to include a new blinded ID that will allow for the future linking to non-clinical data (e.g., genomic data). Other than the IDs, the datasets are identical. We recommend that NCT00326898-D3 and NCT00326898-D4 be used.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT00326898 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®